Hyperfine, Inc. (HYPR)
0.8133
-0.02
(-2.83%)
USD |
NASDAQ |
Sep 04, 16:00
0.8299
+0.02
(+2.04%)
After-Hours: 20:00
Hyperfine Total Liabilities (Quarterly) : 26.24M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.24M |
| March 31, 2026 | 25.98M |
| December 31, 2025 | 14.26M |
| September 30, 2025 | 14.64M |
| June 30, 2025 | 10.11M |
| March 31, 2025 | 10.26M |
| December 31, 2024 | 9.861M |
| September 30, 2024 | 11.06M |
| June 30, 2024 | 9.849M |
| March 31, 2024 | 9.805M |
| December 31, 2023 | 9.80M |
| September 30, 2023 | 9.297M |
| Date | Value |
|---|---|
| June 30, 2023 | 9.315M |
| March 31, 2023 | 9.365M |
| December 31, 2022 | 10.33M |
| September 30, 2022 | 13.35M |
| June 30, 2022 | 11.20M |
| March 31, 2022 | 12.26M |
| December 31, 2021 | 16.25M |
| September 30, 2021 | 9.191M |
| June 30, 2021 | 8.603M |
| March 31, 2021 | 7.369M |
| December 31, 2020 | 4.294M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 57.45B |
| AngioDynamics, Inc. | 96.34M |
| Alphatec Holdings, Inc. | 779.49M |
| AtriCure, Inc. | 160.21M |
| Baxter International, Inc. | 13.61B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.00M |
| Shareholders Equity (Quarterly) | 36.76M |
| Debt to Equity Ratio | 0.3649 |
| Current Ratio | 6.152 |
| Net Debt Paydown Yield | -1.83% |